Related Experiment Videos
Pregnancy outcome with intrahepatic cholestasis
1Department of Obstetrics and Gynecology, Kuopio University Hospital, Finland. seppo.heinonen@kuh.fi
Obstetrics and Gynecology
|August 4, 1999
Summary
Intrahepatic cholestasis in pregnancy increases risks for preterm delivery and neonatal care. Close surveillance and timely delivery upon maturity are recommended for affected pregnancies.
Area of Science:
- Obstetrics and Gynecology
- Perinatal Medicine
- Maternal-Fetal Medicine
Background:
- Intrahepatic cholestasis of pregnancy (ICP) is a liver disorder affecting pregnant women.
- Understanding the risks associated with ICP is crucial for optimizing maternal and fetal outcomes.
Purpose of the Study:
- To assess the risk of adverse pregnancy outcomes in women with intrahepatic cholestasis.
- To compare pregnancy outcomes between women with ICP and the general obstetric population.
Main Methods:
- A retrospective analysis of 91 singleton pregnancies complicated by ICP.
- Logistic regression was used to compare outcomes with a control group of 16,818 women.
Main Results:
- Advanced maternal age (over 35) was associated with increased ICP risk.
- Women with ICP had higher rates of cesarean delivery (25.3% vs. 15.8%) and increased risk of preterm delivery and neonatal care.
- Odds ratios for preterm delivery and neonatal care were 2.73 and 2.15, respectively.
Conclusions:
- Intrahepatic cholestasis adversely impacts fetal development.
- Increased surveillance and delivery at term may mitigate risks associated with ICP.